372 related articles for article (PubMed ID: 26359511)
1. Purinergic Receptors in Thrombosis and Inflammation.
Hechler B; Gachet C
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
[TBL] [Abstract][Full Text] [Related]
2. The platelet P2 receptors in arterial thrombosis.
Gachet C; Léon C; Hechler B
Blood Cells Mol Dis; 2006; 36(2):223-7. PubMed ID: 16466948
[TBL] [Abstract][Full Text] [Related]
3. Agonists and antagonists for P2 receptors.
Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L
Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423
[TBL] [Abstract][Full Text] [Related]
4. P2 receptors, platelet function and pharmacological implications.
Gachet C
Thromb Haemost; 2008 Mar; 99(3):466-72. PubMed ID: 18327393
[TBL] [Abstract][Full Text] [Related]
5. Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials.
da Silva Ferreira NC; Alves LA; Soares-Bezerra RJ
Curr Drug Targets; 2019; 20(9):919-937. PubMed ID: 30760187
[TBL] [Abstract][Full Text] [Related]
6. P2 receptors and platelet activation.
Kunapuli SP
ScientificWorldJournal; 2002 Feb; 2():424-33. PubMed ID: 12806027
[TBL] [Abstract][Full Text] [Related]
7. Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis.
Wu XM; Zhang N; Li JS; Yang ZH; Huang XL; Yang XF
Purinergic Signal; 2023 Mar; 19(1):265-272. PubMed ID: 34981330
[TBL] [Abstract][Full Text] [Related]
8. P2 Receptors in Cardiac Myocyte Pathophysiology and Mechanotransduction.
Woo SH; Trinh TN
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383710
[TBL] [Abstract][Full Text] [Related]
9. Acute arterial thrombosis in the absence of inflammation: the stress-related anti-inflammatory hormone ACTH participates in platelet-mediated thrombosis.
Pozzi AO; Bernardo E; Coronado MT; Punchard MA; González P; Fantidis P
Atherosclerosis; 2009 May; 204(1):79-84. PubMed ID: 18834983
[TBL] [Abstract][Full Text] [Related]
10. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
12. P2Y12 receptor in platelet activation.
Kim S; Kunapuli SP
Platelets; 2011; 22(1):56-60. PubMed ID: 21231822
[TBL] [Abstract][Full Text] [Related]
13. P2Y
Mansour A; Bachelot-Loza C; Nesseler N; Gaussem P; Gouin-Thibault I
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092903
[TBL] [Abstract][Full Text] [Related]
14. Action of natural products on p2 receptors: a reinvented era for drug discovery.
Faria R; Ferreira L; Bezerra R; Frutuoso V; Alves L
Molecules; 2012 Nov; 17(11):13009-25. PubMed ID: 23117439
[TBL] [Abstract][Full Text] [Related]
15. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
[TBL] [Abstract][Full Text] [Related]
16. The platelet ATP and ADP receptors.
Oury C; Toth-Zsamboki E; Vermylen J; Hoylaerts MF
Curr Pharm Des; 2006; 12(7):859-75. PubMed ID: 16515502
[TBL] [Abstract][Full Text] [Related]
17. Research articleHemolysis in human erythrocytes by Clostridium perfringens epsilon toxin requires activation of P2 receptors.
Gao J; Xin W; Huang J; Ji B; Gao S; Chen L; Kang L; Yang H; Shen X; Zhao B; Wang J
Virulence; 2018; 9(1):1601-1614. PubMed ID: 30277122
[TBL] [Abstract][Full Text] [Related]
18. Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.
Ai X; Dong X; Guo Y; Yang P; Hou Y; Bai J; Zhang S; Wang X
Purinergic Signal; 2021 Jun; 17(2):229-240. PubMed ID: 33751327
[TBL] [Abstract][Full Text] [Related]
19. Role of purinergic receptor polymorphisms in human bone.
Wesselius A; Bours MJ; Agrawal A; Gartland A; Dagnelie PC; Schwarz P; Jorgensen NR
Front Biosci (Landmark Ed); 2011 Jun; 16(7):2572-85. PubMed ID: 21622196
[TBL] [Abstract][Full Text] [Related]
20. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
